Host: |
Mouse |
Applications: |
IHC/IF |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Carbonic Anhydrase 9/CA9 is suitable for use in Immunohistochemistry and Immunofluorescence research applications. |
Clonality: |
Monoclonal |
Clone ID: |
SM0424 |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.15% ProClin300, 100 Mu g/mL BSA and 50% glycerol. |
Purification: |
Affinity purification |
Dilution Range: |
IHC/IF (H) 1:500-1500 |
Storage Instruction: |
Store at-20C for up to one year, and avoid repeated freeze-thaw cycles. |
Gene Symbol: |
CA9 |
Gene ID: |
768 |
Uniprot ID: |
CAH9_HUMAN |
Immunogen: |
Recombinant protein corresponding to Human CA9 |
Post Translational Modifications | Asn-346 bears high-mannose type glycan structures. |
Function | Catalyzes the interconversion between carbon dioxide and water and the dissociated ions of carbonic acid (i.e. bicarbonate and hydrogen ions). |
Protein Name | Carbonic Anhydrase 9Carbonate Dehydratase IxCarbonic Anhydrase IxCa-IxCaixMembrane Antigen MnP54/58nRenal Cell Carcinoma-Associated Antigen G250Rcc-Associated Antigen G250Pmw1 |
Database Links | Reactome: R-HSA-1234158Reactome: R-HSA-1475029 |
Cellular Localisation | NucleusNucleolusCell MembraneSingle-Pass Type I Membrane ProteinCell ProjectionMicrovillus MembraneFound On The Surface Microvilli And In The NucleusParticularly In Nucleolus |
Alternative Antibody Names | Anti-Carbonic Anhydrase 9 antibodyAnti-Carbonate Dehydratase Ix antibodyAnti-Carbonic Anhydrase Ix antibodyAnti-Ca-Ix antibodyAnti-Caix antibodyAnti-Membrane Antigen Mn antibodyAnti-P54/58n antibodyAnti-Renal Cell Carcinoma-Associated Antigen G250 antibodyAnti-Rcc-Associated Antigen G250 antibodyAnti-Pmw1 antibodyAnti-CA9 antibodyAnti-G250 antibodyAnti-MN antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance